Global Myeloproliferative Disorders (MPD) Treatment Market Share

Market Share of Global Myeloproliferative Disorders (MPD) Treatment Industry

The myeloproliferative disorders (MPD) treatment market is consolidated in nature due to the presence of a few key companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including AbbVie, Bristol-Myers Squibb, Incyte Corporation, Mylan NV, Novartis AG, and Pfizer among others.

Myeloproliferative Disorders Treatment Market Leaders

1. Novartis AG

2. Bristol-Myers Squibb

3. Incyte Corporation

4. Takeda Pharmaceutical Company Limited

5. Viatris (Mylan N.V.)

*Disclaimer: Major Players sorted in no particular order